-+ 0.00%
-+ 0.00%
-+ 0.00%

Acme United (ACU) Stock Climbs As Q3 Results Get Lift From Tariff Refund

Simply Wall St·10/28/2026 01:23:24
Listen to the news

Acme United just dropped Q3 2026 numbers and the stock did not shrug. Shares closed at US$65.78, up 3.5% on the day, as traders latched onto a sharp jump in profitability helped by a tariff refund and a richer mix from higher margin products.

The headline story is simple. Revenue came in at US$58.0m and net income reached US$3.4m, with earnings per share at US$0.88. The market treated that as a clean beat. The actual report shows a more complicated picture of one off boosts and underlying trends that need unpacking.

Like that clean headline beat from Acme United but wary that one off tariff refunds and product mix shifts will not repeat every quarter? Benchmark this update against a wider set of resilient operators in our list of solid balance sheet and fundamentals stocks (24 results)

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs. Q3 2025): US$58.0m vs. US$49.1m (higher year on year, helped by a tariff refund and a richer product mix)
  • Net Income (Q3 2026 vs. Q3 2025): US$3.4m vs. US$1.9m (higher year on year, partly driven by a one-off tariff benefit)
  • Basic EPS (Q3 2026 vs. Q3 2025): US$0.88 vs. US$0.50 (Q3 earnings per share improved, with a material boost from the refund)
  • Gross Margin (Q3 2026 vs. Q3 2025): 45.3% vs. 39.1% (margin stepped up, with roughly 380 bps net uplift from tariff refund and DMT plant closure effects)

Earnings tell you what Acme United reported this quarter, but the cash flowing through the business is what valuation focused investors usually watch most closely.

Based on Acme United's cash flows alone, the stock could be a dramatic 48% undervalued.

NYSEAM:ACU Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026
NYSEAM:ACU Trailing 12-Month Revenue & Expenses Breakdown as at Oct 2026

Acme United: Earnings Upside For The Optimists

For anyone leaning optimistic on Acme United, this quarter helps. Headline revenue of US$58.0m and net income of US$3.4m came with a sizeable tariff refund, yet adjusted profit still moved higher. Gross margin reached 45.3% even after DMT closure costs, which suggests the richer mix from First Aid and My Medic is pulling its weight. Cash generation of US$13.8m over 12 months, together with a 3.5% share price gain after the release, shows investors rewarding a business that is turning product breadth into healthier economics.

Stress Points For The Cautious Acme United Holder

There is still plenty for cautious holders to watch at Acme United. A meaningful slice of Q3 earnings came from a US$6.0m tariff refund, which flatters both net income and margin. Net debt moved to US$29.7m as acquisitions, higher inventories and dividends soaked up cash, so the balance sheet is working harder. Plant closure charges and outsourcing of DMT production add execution risk. If demand for Westcott and other retail exposed lines softens, elevated stock levels and borrowing costs could start to weigh more heavily on future results.

After plant closure costs, rising inventories and fresh borrowing, it is fair to ask whether these are isolated issues or early signs of deeper strain. Review the independent risk analysis for Acme United which shows 3 important warning signs

Hunt For Mispriced Cash Generators

Acme United just reported a quarter that mixed steady operational progress with some non-recurring items. The real opportunity is finding stocks that could be undervalued before the market adjusts their prices.

  • Company 1 - 15% below our estimate - serves hyperscale data center builds with electrical systems and infrastructure projects supported by a sizable contracted backlog.
  • Company 2 - 46% below our estimate - converts a large pipeline of data center and modular construction projects into installation, maintenance and monitoring services.
  • Company 3 - 22% below our estimate - ties cloud infrastructure, workplace software and AI tools together so customers consolidate technology spending on one integrated platform.

That is three of the list. See all 29 potentially undervalued companies →